I'll try to be quick.
Minister, thank you for being here today.
This has to do with access to medications and the speculation that, in the current negotiations over the comprehensive economic trade agreement with the European Union, there will be provisions to extend patent protection, which is going to cost our health care system up to $2 billion, but the speculation seems to be around $1 billion.
I am wondering how, when there are such great challenges to access to pharmaceuticals already within our health care system, we can justify adding those kinds of costs to our health care system and those barriers to Canadian citizens in their efforts to access health care.